Healthcare -
Biotechnology - NASDAQ - US
$ 25.33
11 %
$ 33.6 M
Market Cap
-0.38
P/E
LYRA - OPERATING INCOME
Operating Income LYRA - Lyra Therapeutics, Inc.
-96.3 M
LAST VALUE
-30.81%
2 YEAR CAGR
-42.29%
5 YEAR CAGR
0.00%
10 YEAR CAGR